Via TheLocal.no: Norway-led team prove Ebola vaccine works. Excerpt:
A Norwegian-led research team has developed what is likely to be the first effective vaccine against the deadly Ebola virus, that has killed more than 11,000 people in the still ongoing outbreak in West Africa.
The team's study, published in The Lancet, is based on data from the vaccination of 4,000 people in Guinea.
The Guinean ministry of Health, the World Health Organization, Doctors Without Borders and the Norwegian Institute of Public Health all collaborated on the research, which showed that a single vaccination could give complete protection against the disease.
"This will be invaluable for the affected countries and the world," Foreign Minister Børge Brende told Norway's VG newspaper.
"I am glad that Norway has played an active role in this."
According to John-Arne Røttingen from the Norwegian Institute of Public Health, who guided the research, the result was considerably better than expected.
"So far it seems that the vaccine offers full protection, which means that everyone who is vaccinated is protected against Ebola after seven days," he said.
"Still, this is still early and relatively small numbers, and that is why we will keep working until we get more robust figures, but we hadn't dreamed of such a strong effect."
He said the researchers had decided to vaccinate everyone in their control group immediately, rather than delay administering it by three weeks, as originally intended, believing that delaying them access to such an effective treatment would be unethical.
The vaccine was originally developed by the Canadian Institute of Public Health, which has licensed it to the US pharmaceutical firm Merck.
MSF has also been involved in the tests, and its statement on their success is here.